Crossmark

Targeted next-generation sequencing has comparable clinical value to metagenomic NGS for pulmonary infections in hematological malignancy patients: a real-world propensity score-matched study

Crossref DOI link: https://doi.org/10.1186/s40001-026-03893-0

Published Online: 2026-01-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xiao, Yulian

Tang, Yishu

Yan, Yuhan

Cheng, Qian

Chen, Xin

Wang, Liwen

Li, Xin
License Information

Text and Data Mining valid from 2026-01-17

Version of Record valid from 2026-03-31
More Information

Article History

Received: 17 July 2025

Accepted: 9 January 2026

First Online: 17 January 2026

Declarations

:

: The study adhered to the principles of the Declaration of Helsinki and was approved by the Medical Ethics Committee of The Third Xiangya Hospital (No. 24603). Due to its retrospective nature, patient consent was waived.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below